ABSTRACT
ABSTRACT Introduction: Brazil has many inequities in the healthcare provided nationwide. Therefore, in order to access challenges in treatment, available resources and current practices, to identify barriers in delivering a good quality of care among Brazilian centers treating children and adolescents with Non-Hodgkin Lymphoma (NHL) and to generate a future prospective guideline, a customized online survey was distributed to pediatric hematologists and oncologists across the country. Results: A total of 97 surveys were completed (35% response rate), from 47 cities in all Brazilian regions and 79 units of care, with a median of 1 answer by the center (range 1 - 5). Most respondents work at an institution supported exclusively by public/philanthropic resources (58%), with an average of 5 to 9 new cases/year (49%), and 41% have 4 to 6 oncologists/centers. Additionally, 22% have no easy access to the intensive care unit, 26% have no access to Rasburicase, 28% have no access to Rituximabe as front-line therapy and 41% have unreliable methotrexate monitoring levels. Those differences cannot be explained thoroughly by regional wealth variances, nor by the financing model. Regarding the pathology service, 70% consider having reasonable quality assistance, but the timeframe to deliver diagnosis is satisfactory to 46%. There is no uniform management of care, with the current guideline from the Sociedade Brasileira de Oncologia Pediátrica being adopted by 54 to 59%, depending on the NHL subtype. Conclusion: This study provides insights into the heterogeneity of care among Brazilian centers. Recognizing those diversities will support the design of effective strategies and collaboration nationwide.
ABSTRACT
OBJETIVOS: Avaliar a prevalência de anemia entre os pré-escolares da rede pública de Ilhabela (SP) e a resposta ao tratamento instituído. MÉTODOS: Estudo com 667 pré-escolares, entre 2007 e 2008. As crianças foram avaliadas na escola quanto ao peso, estatura e concentração de hemoglobina. As anêmicas foram tratadas com sulfato ferroso por 12 semanas, com uma consulta intermediária e outra ao final. RESULTADOS: A prevalência de anemia foi de 25,6 por cento (170 crianças). A concentração de hemoglobina mais baixa foi de 9,5 g/dL. A maior prevalência de anemia (36 por cento) ocorreu em crianças de 60 a 65 meses de idade. A mediana da concentração de hemoglobina evoluiu de 10,5 g/dL para 11,8 g/dL ao final do tratamento, recuperando 76 por cento das crianças. CONCLUSÃO: A identificação de crianças anêmicas nas escolas, o pronto tratamento da anemia e o acompanhamento durante o tratamento mostrou ser estratégia eficaz no combate a esse importante problema de saúde pública.
OBJECTIVES: To assess the prevalence of anemia among children attending public preschools in Ilhabela, state of São Paulo, Brazil, and their response to a treatment regimen. METHODS: Between 2007 and 2008, the weight, height, and hemoglobin levels of 667 children were measured in the school setting. Anemic children were prescribed a 12-week course of ferrous sulfate, and follow-up assessment visits were scheduled for halfway through this course and the end of treatment. RESULTS: The prevalence of anemia was 25.6 percent (N = 170). The lowest hemoglobin level measured was 9.5 g/dL. Anemia was most prevalent (36 percent) in children between the ages of 60 and 65 months. Median hemoglobin levels rose to 11.8 g/dL from 10.5 g/dL after treatment; 76 percent of children recovered from anemia. CONCLUSION: Screening for anemia in the school setting and prompt therapy, including mid-treatment follow-up, proved to be an effective strategy for facing this major public health issue.